Tanishi Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 6.00 M
About Tanishi Lifescience
Tanishi Lifescience Private Limited (TLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 July 2017 (Seven years and six months 29 days old ). Its registered office is in Bharuch, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹6.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Marmik Patel, Ravi Patel, and Hitachiben Patel serve as directors at the Company.
Company Details
- Location Bharuch, Gujarat
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100GJ2017PTC098440
- Company No.
098440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2017
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Tanishi Lifescience?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Marmik Patel  | Director | 26-Jul-2017 | Current |
| Ravi Patel | Director | 26-Jul-2017 | Current |
| Hitachiben Patel | Additional Director | 28-Nov-2018 | Current |
Financial Performance of Tanishi Lifescience.
Tanishi Lifescience Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tanishi Lifescience?
In 2019, Tanishi Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tanishi Medi Services Private LimitedMarmik Patel and Ravi Patel are mutual person
Charges (Loans)
₹0
₹6.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2018 | State Bank Of India | ₹6.00 M | Satisfied |
How Many Employees Work at Tanishi Lifescience?
Tanishi Lifescience has a workforce of 7 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tanishi Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanishi Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
